Yu‐Chin Lin

776 total citations
23 papers, 613 citations indexed

About

Yu‐Chin Lin is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Yu‐Chin Lin has authored 23 papers receiving a total of 613 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 3 papers in Immunology. Recurrent topics in Yu‐Chin Lin's work include Immune Cell Function and Interaction (3 papers), Cancer-related Molecular Pathways (3 papers) and Virus-based gene therapy research (2 papers). Yu‐Chin Lin is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cancer-related Molecular Pathways (3 papers) and Virus-based gene therapy research (2 papers). Yu‐Chin Lin collaborates with scholars based in Taiwan, Japan and United States. Yu‐Chin Lin's co-authors include Ching‐Chow Chen, Tong‐Rong Jan, Chung‐Hsiung Huang, Jim‐Min Fang, Tzu-Tang Wei, Jin‐Yuan Shih, Chi Liu, Li-Yu Chen, Ann‐Lii Cheng and Yi‐Ting Lin and has published in prestigious journals such as Cancer Research, Oncogene and Clinical Cancer Research.

In The Last Decade

Yu‐Chin Lin

22 papers receiving 609 citations

Peers

Yu‐Chin Lin
Yu‐Chin Lin
Citations per year, relative to Yu‐Chin Lin Yu‐Chin Lin (= 1×) peers Gonzalo Rodríguez‐Berriguete

Countries citing papers authored by Yu‐Chin Lin

Since Specialization
Citations

This map shows the geographic impact of Yu‐Chin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu‐Chin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu‐Chin Lin more than expected).

Fields of papers citing papers by Yu‐Chin Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu‐Chin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu‐Chin Lin. The network helps show where Yu‐Chin Lin may publish in the future.

Co-authorship network of co-authors of Yu‐Chin Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu‐Chin Lin. A scholar is included among the top collaborators of Yu‐Chin Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu‐Chin Lin. Yu‐Chin Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Coveler, Andrew L., Benjamin L. Schlechter, Tanios Bekaii‐Saab, et al.. (2024). A multicenter phase Ia study of AbGn-107, a novel antibody–drug conjugate, in patients with advanced gastrointestinal cancer. Investigational New Drugs. 42(2). 221–228. 1 indexed citations
3.
Lin, Yu‐Chin, Sun‐Lin Chung, Shigenori Maruyama, Ade Kadarusman, & Hao‐Yang Lee. (2023). The ephemeral history of Earth’s youngest supra-subduction zone type ophiolite from Timor. Communications Earth & Environment. 4(1). 1 indexed citations
4.
Liu, Shuchun, et al.. (2021). Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity. Phytomedicine. 95. 153876–153876. 29 indexed citations
5.
Lee, Der‐Yen, Yu‐Chin Lin, & Geen‐Dong Chang. (2021). Biochemical Regulation of the Glyoxalase System in Response to Insulin Signaling. Antioxidants. 10(2). 326–326. 6 indexed citations
6.
Chen, Li-Yu, Yu‐Chin Lin, Jin‐Yuan Shih, et al.. (2018). Epithelial-mesenchymal transition (EMT) beyond EGFR mutations per se is a common mechanism for acquired resistance to EGFR TKI. Oncogene. 38(4). 455–468. 178 indexed citations
7.
Shen, Chien‐Chang, et al.. (2018). Iron oxide nanoparticles attenuate T helper 17 cell responses in vitro and in vivo. International Immunopharmacology. 58. 32–39. 18 indexed citations
8.
Wei, Tzu-Tang, Yi‐Ting Lin, Chia‐Tung Shun, et al.. (2016). Prevention of Colitis and Colitis-Associated Colorectal Cancer by a Novel Polypharmacological Histone Deacetylase Inhibitor. Clinical Cancer Research. 22(16). 4158–4169. 31 indexed citations
9.
Huang, Chung‐Hsiung, Chia‐Chi Wang, Yu‐Chin Lin, Masatoshi Hori, & Tong‐Rong Jan. (2016). Oral administration with diosgenin enhances the induction of intestinal T helper 1-like regulatory T cells in a murine model of food allergy. International Immunopharmacology. 42. 59–66. 13 indexed citations
10.
Wei, Tzu-Tang, Yi‐Ting Lin, Wenshu Chen, et al.. (2016). Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer. EBioMedicine. 10. 124–136. 26 indexed citations
11.
Wang, Tai‐Chi, et al.. (2015). WTC‐01, a novel synthetic oxime‐flavone compound, destabilizes microtubules in human nasopharyngeal carcinoma cellsin vitroandin vivo. British Journal of Pharmacology. 172(19). 4671–4683. 4 indexed citations
12.
Lin, Yu‐Chin, Tzu-Tang Wei, Wen‐Chih Huang, et al.. (2014). Metformin sensitizes anticancer effect of dasatinib in head and neck squamous cell carcinoma cells through AMPK-dependent ER stress. Oncotarget. 5(1). 298–308. 43 indexed citations
13.
Lin, Yu‐Chin, et al.. (2014). Abstract 5514: Metformin sensitizes anticancer effect of dasatinib through AMPK-dependent ER stress in head and neck squamous cell carcinoma cells. Cancer Research. 74(19_Supplement). 5514–5514. 1 indexed citations
14.
Lin, Yu‐Chin, Chung‐Ping Yu, Shiuan-Pey Lin, et al.. (2014). Potential modulation on BCRP and MRP 4 by onion: in vivo and ex-vivo studies. Journal of Functional Foods. 8. 243–251. 3 indexed citations
15.
Lin, Yu‐Chin, et al.. (2012). CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells. Oral Oncology. 48(7). 585–593. 54 indexed citations
16.
Chen, I‐Li, Jih‐Jung Chen, Yu‐Chin Lin, et al.. (2012). Synthesis and antiproliferative activities of N-(naphthalen-2-yl)acetamide and N-(substituted phenyl)acetamide bearing quinolin-2(1H)-one and 3,4-dihydroquinolin-2(1H)-one derivatives. European Journal of Medicinal Chemistry. 59. 227–234. 12 indexed citations
17.
18.
Shia, Chi‐Sheng, Suresh Govindan, Yu‐Chi Hou, et al.. (2010). Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: An ex vivo approach. Journal of Ethnopharmacology. 133(2). 426–433. 37 indexed citations
19.
Yang, Cheng‐Ta, Yu‐Chin Lin, Chun‐Liang Lin, et al.. (2005). Oncolytic herpesvirus with secretable angiostatic proteins in the treatment of human lung cancer cells.. PubMed. 25(3B). 2049–54. 21 indexed citations
20.
Huang, Chiu-Chen, Yi-Fen Lu, Wen‐Chuan Hsieh, et al.. (2005). A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases. European Journal of Immunology. 35(7). 2239–2249. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026